TSX VENTURE COMPANIES
BULLETIN V2024-0770
KHIRON LIFE SCIENCES CORP. ("KHRN.H") ("KHRN.WT. H")
[formerly Khiron Life Sciences Corp. ("KHRN") ("KHRN.WT")
BULLETIN TYPE: Transfer and New Addition to NEX, Symbol Change, Remain Suspended
BULLETIN DATE: March 13, 2024
TSX Venture Tier 2 Company
In accordance with TSX Venture Policy 2.5, the Company has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on Friday, March 15, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Montreal to NEX.
As of March 15, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies.
The trading symbol for the Company will change from KHRN to KHRN.H and KHRN.WT to KHRN.WT. H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market.
Further to the TSX Venture bulletin dated May 8, 2023, trading in the shares of the Company will remain suspended.
Members are prohibited from trading in the securities of the Company during the period of the suspension or until further notice.
_______________________________________
|
|
